Get all your news in one place.
100's of premium titles.
One app.
Start reading
LiveScience
LiveScience
Julie Goldenberg

Severe COVID-19 may shrink cancer tumors, early data suggest

A woman works in a laboratory.

Immune cells produced during a severe COVID-19 infection may cause cancerous tumors to shrink, research in mice suggests.

The study, published Friday (Nov. 15) in The Journal of Clinical Investigation, found that genetic information from the virus that causes COVID-19 led the immune system to produce special cells with anti-cancer properties. These immune cells, a type of white blood cell called monocytes, helped shrink several types of cancer in mice.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.